RVL Pharmaceuticals Announces $5M Registered Direct Offering Of 11,870,846 Shares Priced At $0.4212/Share
Portfolio Pulse from Benzinga Newsdesk
RVL Pharmaceuticals has announced a registered direct offering of 11,870,846 shares priced at $0.4212 per share, raising $5 million in total.
August 16, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RVL Pharmaceuticals' stock may be impacted by the announcement of a registered direct offering of nearly 12 million shares.
The announcement of a registered direct offering often leads to a decrease in the stock price due to dilution of shares. As RVL Pharmaceuticals is issuing nearly 12 million new shares, existing shareholders' stake in the company will be diluted, which could lead to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100